The enzyme activation-induced deaminase (AID) triggers antibody diversification in B cells by catalyzing deamination and consequently mutation of immunoglobulin genes. To minimize off-target deamination, AID is restrained by several regulatory mechanisms including nuclear exclusion, thought to be mediated exclusively by active nuclear export. Here we identify two other mechanisms involved in controlling AID subcellular localization. AID is unable to passively diffuse into the nucleus, despite its small size, and its nuclear entry requires active import mediated by a conformational nuclear localization signal. We also identify in its C terminus a determinant for AID cytoplasmic retention, which hampers diffusion to the nucleus, competes with nuclear import and is crucial for maintaining the predominantly cytoplasmic localization of AID in steady-state conditions. Blocking nuclear import alters the balance between these processes in favor of cytoplasmic retention, resulting in reduced isotype class switching.
The enzyme activation-induced deaminase (AID) triggers antibody diversification in B cells by catalyzing deamination and consequently mutation of immunoglobulin genes. To minimize off-target deamination, AID is restrained by several regulatory mechanisms including nuclear exclusion, thought to be mediated exclusively by active nuclear export. Here we identify two other mechanisms involved in controlling AID subcellular localization. AID is unable to passively diffuse into the nucleus, despite its small size, and its nuclear entry requires active import mediated by a conformational nuclear localization signal. We also identify in its C terminus a determinant for AID cytoplasmic retention, which hampers diffusion to the nucleus, competes with nuclear import and is crucial for maintaining the predominantly cytoplasmic localization of AID in steady-state conditions. Blocking nuclear import alters the balance between these processes in favor of cytoplasmic retention, resulting in reduced isotype class switching.
AID is the enzyme responsible for the diversification of rearranged antibody genes in activated B cells 1, 2 . AID acts as a mutator by deaminating deoxycytidine in single-stranded DNA, thereby changing the base, cytosine, into a uracil (reviewed in ref. 3) . Through further processing by DNA-repair enzymes that recognize uracil in DNA, this single biochemical activity triggers different genetic modifications that are crucial for a proper antibody response (reviewed in refs. 3, 4) . Thus, AID initiates somatic hypermutation (SHM) and Ig gene conversion at the immunoglobulin (Ig) variable regions, allowing for affinity maturation of the antibody response 1, 2, 4 . AID also initiates class-switch recombination (CSR), which exchanges the exons encoding the Fc region of the antibody from the default IgM to another isotype 1, 2, 5 . All the known components in these pathways except for AID are ubiquitous DNA-repair enzymes (reviewed in refs. [3] [4] [5] . Indeed, AID can trigger SHM and CSR in non-B cell models 6, 7 and, because such a mutagenic and recombinogenic enzyme is potentially dangerous, it needs to be tightly regulated. This is highlighted by the cancer-predisposition phenotype observed in transgenic mice overexpressing AID 7 , by the finding that ectopic SHM can occur in protooncogenes and tumor-suppressor genes [8] [9] [10] and by the involvement of AID in oncogenic chromosomal translocations 11, 12 . AID is normally induced in germinal center B cells 13 , but to ensure that the genetic modifications it can cause are largely restricted to the Ig loci there are multiple points of post-transcriptional regulation, such as regulation of mRNA stability and translation [14] [15] [16] , subcellular localization 17, 18 , protein stability 19 and modification by phosphorylation [20] [21] [22] .
The subcellular localization of AID is especially interesting. The initially puzzling observation that a green fluorescent protein (GFP)-AID fusion was exclusively cytoplasmic 23 was later explained by the fact that AID is a nuclear-cytoplasmic shuttling protein. The mechanism by which AID is transported out of the nucleus is known; a leucine-rich nuclear export signal (NES) at the C terminus of AID is recognized by the exportin CRM1 (refs. 17,18,24) . However, the mechanism by which AID enters the nucleus has not been studied in any detail and the observations available are inconsistent. Whereas one report proposes a classical bipartite NLS at the N terminus of AID 17 , others failed to find evidence for such a signal, suggesting that AID may passively diffuse into the nucleus 18, 24 . To address this controversy, we have investigated the mechanism by which human AID enters the nucleus. We find that, despite its small size, AID is actually unable to passively diffuse into the nucleus, requiring instead active import. In addition, we describe a previously uncharacterized cytoplasmic retention mechanism for AID that contributes to the observed nuclear exclusion in steady state, thus restraining its function.
RESULTS

AID is actively imported into the nucleus
The expression of AID-GFP in several cell types resulted in exclusive cytoplasmic localization in steady state, with this changing to nuclear localization after inhibition of CRM1-mediated nuclear export by leptomycin B, as previously reported 17, 18, 24 . We indeed observed that AID-GFP accumulated in the nucleus after leptomycin B treatment in most transiently transfected 293T cells (80% after 4 h, n ¼ 206) and HeLa cells (96% after 1 h, n ¼ 53) and in stably expressing Ramos B cells (93% after 1 h, n ¼ 91). Moreover, AID-GFP accumulated in the nucleus with different kinetics depending on the cell line (Fig. 1a) . These observations are not consistent with the previous proposal that AID subcellular localization is determined exclusively by active nuclear export and nuclear entry occurring by passive diffusion 18, 24 . If that were the case, AID-GFP would be expected to follow the mass action law and reach a more homogeneous distribution between the nucleus and cytoplasm after leptomycin B treatment. Rather, additional mechanisms seem to control AID localization.
As active translocation across nuclear pores requires energy 25, 26 , nuclear proteins that are not retained should diffuse out of the nucleus when ATP is depleted 27 . We depleted ATP from HeLa cells by glucose deprivation and assessed the localization of AID L198S-GFP, a constitutively nuclear AID variant carrying a point mutation that inactivates the NES 18 , and NLS SV40 -GFP carrying the NLS of the Simian virus 40 large T antigen. The latter was used as a positive control because it is small enough to diffuse through the nuclear pores and its nuclear localization is mediated only by the NLS. ATP depletion led to redistribution of NLS SV40 -GFP throughout the cell in 490% of the cells and B40% of the cells transfected with AID L198S-GFP (Fig. 1b) . Notably, this redistribution was reversible, as both proteins accumulated back into the nucleus upon transfer of the cells to complete medium (Fig. 1b) . The differential sensitivity of AID L198S-GFP to this treatment compared to NLS SV40 -GFP may suggest nuclear retention of the former, which could be due to a larger protein size, its binding to DNA 28 or to nuclear factors 29 , as well as a previously proposed retention by DNA damage 24 . We did not pursue this observation further. Nevertheless, the fact that energy was needed to maintain AID nuclear localization in a substantial proportion of cells supports the existence of active nuclear import.
The B50-kDa size of the AID-GFP fusion protein is at the upper limit of the cut-off imposed by the diameter of the nuclear pore 29, 30 . We confirmed that AID could mediate active nuclear import by increasing the size of the fusion protein so as to preclude diffusion. As protein shape can strongly influence the ability to diffuse 30 , we used apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like (APOBEC)-2 (A2) as control. Given the sequence similarity of AID with A2 and APOBEC3G [31] [32] [33] , the predicted three-dimensional structure of AID safely allows us to postulate that the monomers of A2 (25.7 kDa) and AID (23.9 kDa) will have a similar general folding and, therefore, shape ( Supplementary Fig. 1 online) . Several controls confirmed that A2-GFP has no information for nuclear import or export, and therefore its localization throughout the cell is achieved by passive diffusion (Fig. 1c and Supplementary Fig. 2 online) . Thus, increasing the size of the A2-GFP to B75 kDa by adding b-lactamase (b-Lac) or to B175 kDa using b-galactosidase (b-Gal) resulted in exclusive cytoplasmic localization, even after leptomycin B treatment. In contrast, AID-b-Lac-GFP accumulated in the nucleus upon leptomycin B treatment, and the export-deficient mutants AID L198S-b-Lac-GFP and AID 181-b-Lac-GFP (which lacks the last 17 residues of AID) were constitutively nuclear (Fig. 1c) . Moreover, AID 181 was also able to change the subcellular localization of b-Gal-GFP (B150 kDa) from cytoplasmic to nuclear, as did the bona fide nuclear protein uracil-DNA glycosylase 2 (UNG2) 34 (Fig. 1d) . We conclude that AID nuclear import is active.
Most of AID protein is necessary to mediate nuclear import The existence of an NLS in AID is controversial 17, 18, 24 . We systematically investigated whether AID contained a sequence that could be sufficient to act as an NLS. To this end, we generated a collection of nested C-terminal deletions of AID fused to the N terminus of GFP (Fig. 2a) . Most of these fusion proteins were distributed throughout the cells. Only AID 181 and AID 187 (which have the last 17 and 10 residues truncated, respectively) fully transported GFP into the nucleus of 293T, HeLa and Ramos cells (Fig. 2a-c and Supplementary Fig. 3 online) . To further examine whether the N-terminal domain of AID contained an NLS without being obscured by the effects of diffusion, we increased the size of the fusion proteins by including b-Gal. Both AID 40-b-Gal-GFP and AID 54-b-Gal-GFP (carrying the N-terminal 40 and 50 residues of AID, respectively) showed only weak nuclear signals, whereas the bipartite NLS from nucleoplasmin and AID 181 efficiently transported b-Gal-GFP into the nucleus of 293T and HeLa cells (Fig. 2d and data not shown) .
To define the regions of AID that are relevant for nuclear import by a different approach, we used a set of five chimeric proteins (AID-A2 #1 to #5), in which different regions of AID were replaced by the homologous A2 regions 35 , with a C-terminal GFP tag ( Fig. 2e and Supplementary Fig. 4 online). AID-A2 #1, in which amino acids 19-57 of AID were replaced with residues 60-96 of A2, remained exclusively cytoplasmic even after nuclear export, establishing this N-terminal domain as crucial for nuclear import. AID-A2 #2 localized throughout the cells after leptomycin B treatment, with AID-A2 #3 and #4 showing similar but milder defects for nuclear accumulation in HeLa cells (Fig. 2e) , which were more evident in 293T cells ( Supplementary Fig. 4 ). As AID-A2 #2, #3 and #4 were catalytically inactive ( Supplementary Fig. 4 ), a structural defect could explain the effect seen on import. AID-A2 #5 had the C termini interchanged, replacing AID positions 154-198 (thus deleting the NES) with the last 31 amino acids of A2 (which has no detectable NES). Despite this exchange, AID-A2 #5 was not nuclear (as would be expected if it had a linear NLS) but was distributed throughout the cell. AID-A2 #5-b-Gal-GFP was cytoplasmic ( Supplementary Fig. 4 ), confirming the loss of active import. Notably, AID-A2 #5 was active ( Supplementary Fig. 4 ), ruling out a major folding alteration as a cause of the prevented import. Rather, the localization of AID-A2 #5 is consistent with the results from the C-terminal truncations, indicating that a minimal length of AID (4160 residues) is required to allow efficient active nuclear import and suggesting the need for structural integrity.
AID has a conformational positively charged NLS As AID is likely to oligomerize (see Discussion), we explored the possible influence of AID quaternary structure on nuclear import. AID dimerization through the b2 strand has been proposed on the basis of the structure of A2 (ref. 33) . We tested the effect of perturbing the predicted AID b2, residues 40-53 in our model, on oligomerization by introducing one (F46A), two (F46A Y48A) 33 or four (F46A Y48A R50G N51A, named AID FYRN) mutations. We monitored the ability of each of these mutants to interact with wild-type AID by comparing their efficiency in co-immunoprecipitating with AID-Flag. Whereas AID F46A-GFP and AID F46A Y48A-GFP co-immunoprecipitated similarly to AID-GFP in this assay, AID FYRN-GFP did so much less efficiently or not at all depending on the experiment ( Fig. 3a and data not shown). When AID FYRN-Flag was used as bait, AID FYRN-GFP or AID-GFP failed to co-immunoprecipitate (Fig. 3a) . Failure to oligomerize correlated well with defective nuclear import. Whereas AID F46A-GFP and AID F46A Y48A-GFP showed normal shuttling, AID FYRN-GFP was distributed throughout cells after leptomycin B treatment ( Fig. 3b and Supplementary Fig. 5 online), suggesting defective nuclear import. Indeed, AID FYRN, which has a truncation of the last 17 amino acids, was unable to transport b-Gal into the nucleus, whereas the equivalent unmutated AID 181-b-Gal-GFP did (Fig. 3b) . However, AID FYRN showed a shorter half-life than AID, and it was inactive ( Supplementary Fig. 5 ), so a structural defect cannot be excluded as the cause of the import deficiency. In any case, the failure of AID FYRN to accumulate in the nucleus could not be explained by the diminished stability of the protein as it was still excluded from the nucleus in steady state (that is, export was active) and could be complemented for nuclear accumulation by the addition of NLS SV40 ( Supplementary Fig. 5 ).
While investigating the effect of mutations in the putative oligomerization interfaces of AID 33 , we found three other arginine residues that were important for nuclear import, in addition to Arg50 in FYRN. Mutations R19A, R24W and R112D caused import defects, whereas mutations at Tyr114-Phe115 or Glu117-Asp118 did not ( Supplementary Fig. 5 ). Therefore, we examined in more detail the positively charged N-terminal domain of AID by using chimeras in which this domain was substituted in segments of 3-5 residues with the corresponding A2 positions 35 . Only replacements 19-22, 34-36 or 50-54, all involving basic residues, caused mislocalization of AID after nuclear export inhibition (Fig. 3c) . The combination of two of these replacements, in AID-A2 19-22/34-36 and AID-A2 34-36/50-54, showed a more drastic effect than any single one, resulting in persistent cytoplasmic localization after leptomycin B treatment (Fig. 3d) . Confirming the importance of these determinants for import, untagged AID-A2 #1 or AID-A2 34-36 remained largely cytoplasmic after leptomycin B (Fig. 3e) . Here again the effect of replacing residues 34-36 was less drastic than replacing 19-57 in #1. Thus, at least four determinants involving basic residues collaborate in mediating efficient nuclear import of AID.
The fact that AID requires several nonconsecutive determinants, as well as a substantial length of the protein, for efficient nuclear import strongly suggests a conformational NLS. In fact, when the residues affecting AID import were examined on the threedimensional model it became apparent that they were all in close proximity to each other, within the same surface area, except for residues 34-36, which would however be included in the same surface in a putative AID dimer (Fig. 4a) . Several of the basic residues are exposed in this model, suggesting a positively charged, classical NLS (Fig. 4b) . This kind of NLS is recognized by members of the importin-a family of adaptors 29, 36 . Indeed, AID-Flag was pulled down from extracts of Ramos cells by GST-tagged importin-a1, -a3 and -a5 (Fig. 4c) . We obtained identical results with AID-GFP (not shown). In agreement with our localization results, AID-GFP and the constitutively nuclear AID 181-GFP were pulled down by GST-importin-a3, whereas the A2-GFP control or the import-deficient AID mutants AID FYRN and AID with an N-terminal truncation were not (Fig. 4d) . Altogether, our results are consistent with a conformational, classical NLS determined by the protein folding and, possibly, oligomerization. ...KNVRWAKGRRETYLCYVVKRRDSATSFSLDFGYLRNKNG-CHVE... Hindered diffusion of AID from the cytoplasm The observation that several import-deficient AID-GFP variants (AID-A2 19-22, AID-A2 19-22/34-36, AID-A2 34-36/50-54 and AID R19A) and even untagged AID-A2 #1 remained mainly cytoplasmic after nuclear export inhibition suggested that AID was unable to freely diffuse into the nucleus. We confirmed that AID-A2 #1-GFP remained exclusively cytoplasmic after leptomycin B treatment also in B cells, whereas the similarly sized and shaped A2-GFP was localized throughout the cells (Fig. 5a) . The finding that N-terminal tagging of unmutated AID apparently prevented its nuclear translocation reinforced the possibility of cytoplasmic retention. Thus, GFP-AID and even Flag-AID (B25kDa) failed to enter into the nucleus of B cells and non-B cells after leptomycin B treatment ( Fig. 5b and Supplementary Fig. 6 online) . N-terminal fusions do not seem to affect AID oligomerization 35 ( Supplementary Fig. 6 ) or catalytic activity 28, 33, 35 . Rather, the position of the N terminus with respect to the import determinants suggests that they might be masking the NLS (Fig. 4a) . Regardless of the explanation, the possibility that the persistent cytoplasmic localization of GFP-AID or AID-A2 #1-GFP simply reflects reduced active nuclear import is unlikely, because both remained cytoplasmic up to 6 h after leptomycin B treatment (Fig. 5c and Supplementary Fig. 6 ). By this time, they should have been able to at least passively diffuse into the nucleus given their size, and as demonstrated by the fact that AID L198S-GFP diffused out of the nucleus within 3 h in the energydepletion experiments.
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Finally, we took advantage of the general inhibition of importinmediated nuclear import produced by oxidative stress 37, 38 to further test the cytoplasmic retention of unmutated AID after leptomycin B treatment. Indeed, AID-GFP failed to enter the nucleus in response to leptomycin B in HeLa cells that had been pretreated with hydrogen peroxide, although the distribution of A2-GFP was not affected (Fig. 5d) . Even untagged AID, which is well below the nuclear pore cut-off, remained cytoplasmic in these conditions (Fig. 5e) . Altogether, our results strongly suggest that the diffusion of AID from the cytoplasm is hindered, indicating the existence of a retention mechanism.
A C-terminal cytoplasmic retention determinant To identify regions of AID mediating cytoplasmic retention, we used AID-A2 chimeras that were GFP tagged in their N terminus, so as to block import. Replacing any region of AID that contributes to mediating cytoplasmic retention should, at least by passive diffusion, allow some nuclear localization after leptomycin B treatment. Only GFP-AID-A2 #5 was able to access the nucleus (Fig. 6a) , suggesting that AID residues 158-198 were necessary for cytoplasmic retention. Indeed, AID-A2 #1-GFP, which is cytoplasmic in the presence of leptomycin B, was able to diffuse into the nucleus when the last 17 amino acids of AID were deleted (Fig. 6b) . The differential effect between treating AID-A2 #1-GFP with leptomycin B (Fig. 5c) and deleting the AID C-terminal domain suggests that this region is involved in cytoplasmic retention, apart from its role in nuclear export. This is reinforced by the observation that several nested N-terminal truncations of AID, including a fragment encompassing only residues 164-198, conferred preferentially cytoplasmic localization to GFP in leptomycin B treated 293T and HeLa cells (Fig. 6c and Supplementary Fig. 7 online) . The retention was not as strong as for full-length constructs, suggesting that there are other, perhaps structural, requirements.
We further used AID-A2 #1-GFP in an effort to find point mutations that could distinguish cytoplasmic retention from nuclear export. A mutation that affects export but not retention would be expected to result in nuclear exclusion of AID-A2 #1-GFP both in steady state and after leptomycin B treatment. The L198S mutation, which affects the NES, produced such a phenotype (Fig. 6d) . The exclusively nuclear localization and loss of CRM1 binding of AID L198S-GFP (Fig. 6d,e) indicated that L198S was largely causing export deficiency. Thus, the still preferentially cytoplasmic (a) Detailed location in a putative AID dimer (monomers distinguished in green and pink) of those residues whose mutation, either alone or as part of an amino acid range in AID-A2 chimeras, was found to affect the efficiency of AID nuclear import (blue sticks). Dimerization through b2 as in APOBEC2 (ref. 33 ) was assumed on the basis of similarity and available biochemical data (Supplementary Methods). For clarity, not all mutated residues are labeled. Asterisks indicate residues belonging to the second monomer. Tyr13, Val18 and Trp20, identified elsewhere 43 , are also included. (b) Predicted solvent-accessible surface of the putative AID dimer, with those residues identified in a shown in shades of blue. Positively charged residues within the import determinants are highlighted in bright blue to show the bias for exposed basic amino acids. (c) Glutathione-Sepharose beads loaded with the indicated purified GST-fusion protein were used in pull-down assays on cell extracts from Ramos B cells stably expressing AID-Flag. The material eluted from the beads was analyzed by western blotting using anti-AID. Ponceau S staining of the transferred proteins is shown as an indication of GST-protein precipitation. (d) Pull-down of the indicated GFP-tagged proteins from transiently transfected 293T cell extracts using purified GST of GST-importin-a3 immobilized on glutathioneagarose. The material eluted from the beads and a 2% aliquot of the input lysates were analyzed by western blotting using anti-GFP. Ponceau staining of the transferred proteins is shown as an estimation of similar GST-protein precipitation. Note that AID DN26 and AID 181 were appreciably degraded in the extracts (AID 181 was not visible in the extracts but it was visible after concentration by the pull-down).
localization of AID-A2 #1 L198S-GFP suggests that export and retention can be functionally separated.
Conversely, a mutation that affects retention but not export should result in nuclear exclusion of AID-A2 #1-GFP in steady state but allow diffusion after leptomycin B treatment. We tested several mutations within the C-terminal domain of AID including at Tyr184, which may modulate retention through phosphorylation 20, 21 . Most variants remained cytoplasmic in the context of AID-A2 #1-GFP and shuttled normally in the context of AID-GFP, except for those affecting residues Asp187 and Asp188 (Supplementary Table 1 online). In HeLa cells, AID-A2 #1 D188A-GFP was able to diffuse into the nucleus only after leptomycin B treatment, and AID-GFP bearing D187A or D188A was no longer excluded from the nucleus in steady state (Fig. 6d) . AID D188A-GFP was still largely cytoplasmic in 293T cells, in line with the differences observed between these two cell lines, but the double mutation D187A D188A caused consistent loss of nuclear exclusion in HeLa and 293T cells (Fig. 6d and Supplementary Fig. 7 ), suggesting that both contribute to retention. In addition, two further evidences support the hypothesis that mutations in Asp187 and Asp188 preferentially affect retention rather than export. First, AID D188A and AID D187A D188A co-immunoprecipiated with CRM1 as efficiently as did AID, in stark contrast with AID L198S, which did not (Fig. 6e) . Second, AID D188A-GFP accumulated faster than did AID-GFP in the nucleus of leptomycin B-treated 293T cells, as would be expected for a variant with reduced retention (Fig. 6f and Supplementary Fig. 7 ).
Functional impact of altering AID localization balance
The efficiency of nuclear import and cytoplasmic retention would be predicted to influence AID biology. We performed CSR assays on Aicda À/À mouse B cells complemented by retroviral delivery with AID variants showing compromised nuclear import. Flag-AID was able to rescue isotype switching to IgG1, but it did so less efficiently than did untagged AID (Fig. 7a) . This reduction is more pronounced when the more than two-fold higher protein expression of Flag-AID over AID is factored in (Fig. 7b) . On the other hand, whereas AID-GFP restored isotype switching, GFP-AID was completely unable to do so despite similar expression levels (Fig. 7a,b) . Thus, the effect of N-terminal tags on import seems proportional to their size, in keeping with the proposed masking of the NLS and implying that decreased nuclear import can limit CSR. We tested other AID variants with mutated Figure 3 . Subcellular localization was scored and plotted as in c from two independent experiments. All images are at 630Â magnification, except d and e, which are at 400Â magnification. Scale bars, 10 mm.
import and cytoplasmic retention determinants by this assay. AID FYRN and AID-A2 50-54 were catalytically inactive (Fig. 7c) and could not rescue CSR. AID with single point mutations at Arg50 or Asn51 have been found to be CSR proficient 39 , but our constructs bear additional mutations, which probably explains the difference. On the other hand, AID-A2 19-22, AID-A2 34-36 and AID D187A D188A could not complement CSR, despite being catalytically active (Fig. 7a,c) . The phenotypes of AID-A2 19-22 and AID-A2 34-36 may suggest that nuclear import is necessary for CSR, just as nuclear export seems to be 40 . However, it cannot be excluded that these chimeras have lost binding affinity to relevant AID partners 35 . Mutations at Asp187 and Asp188 may affect the C-terminal domain of AID, which is required for CSR 41, 42 . AID is rapidly degraded in the nucleus 19 , so altering the balance between the mechanisms determining its subcellular localization should influence its half-life. If cytoplasmic retention were important in determining the subcellular localization of AID in steady state, reduced retention of AID should lead to an increased proportion of nuclear protein, resulting in a shorter protein half-life. The degradation kinetics of AID D187A D188A-GFP in DT40 B cells after cycloheximide treatment show that this is the case (Fig. 7d) . As AID D187A D188A-GFP has similar catalytic activity to AID-GFP, structural problems are unlikely to cause the destabilization. Notably, after leptomycin B treatment the degradation of AID D187A D188A-GFP was still more rapid than for AID-GFP (Fig. 7d) , as faster nuclear import would predict.
Finally, to examine the importance of cytoplasmic retention we determined the subcellular localization of endogenous AID in Ramos B cells, in steady state and after leptomycin B treatment, by immunofluorescence. We could not detect any major increase in nuclear AID signal after incubation with leptomycin B (Fig. 7e) . This observation further indicates that nuclear export is not the only mechanism excluding AID from the nucleus and suggests the relevance of cytoplasmic retention for the compartmentalization of AID.
DISCUSSION
The subcellular localization of AID determines how much AID becomes in contact with the genome, probably a crucial parameter in balancing antibody diversification and off-target mutations or translocations. Nuclear export is one mechanism regulating AID localization 17, 18, 24 . We now provide strong evidence of two additional mechanisms influencing human AID subcellular distribution: active nuclear import and cytoplasmic retention.
Active nuclear import of AID
We demonstrate herein that AID is actively imported into the nucleus. Passive diffusion of AID into the nucleus was previously proposed based on AID's size and the inability of AID fused to the C terminus of a large protein to enter the nucleus 18, 24 . The observation that fusions to the N terminus of AID largely block its nuclear import can now explain this difference. It has also been proposed that AID residues 1-26 contain a classical bipartite NLS 17 . However, the minimal AID fragment mediating nuclear accumulation encompasses the region from the N terminus to somewhere between residues 160 and 181, pointing to the importance of protein conformation. The N-terminal domain contributes at least three of the four noncontiguous, positively charged determinants that we propose conform the AID NLS. Binding to importin-a adaptors, which mediate the nuclear import of proteins with classical basic NLS 29, 30, 36 , is in line with this. Without the threedimensional structure of an AID-importin complex, it is difficult to assign which residues make direct contact and which have a structural role in displaying those residues. Hydrophobic residues Trp20, Val18 and Tyr13, previously identified as necessary for AID nuclear accumulation 43 , may be examples of the latter kind. NLSs often overlap with nucleic acid binding domains 44 . Indeed, Arg24 and Arg112 might be involved in DNA binding by comparison with APO-BEC3G 31 . However, three import-deficient but catalytically active AID-A2 chimeras (#5, 19-22 and 34-36) provide evidence of a separation of function between active import and nucleic acid binding. Similarly to AID, the N-terminal domain of APOBEC1 is necessary but not sufficient for nuclear import 45, 46 , suggesting that APOBEC1 might also have a conformational NLS.
The stoichiometry and architecture of the biologically relevant AID molecule is unknown, but many indirect evidences suggest that it will have quaternary structure 33, 35, 42, 47, 48 , as all cytidine deaminases including the APOBECs do 33, 49, 50 . Predicting AID dimerization through b2 (ref. 33 ) produces a thermodynamically robust model, which is supported by the compromised oligomerization of AID FYRN. The fact that AID FYRN is also compromised for nuclear import suggests a role for AID dimerization in conforming the NLS, which is also consistent with the location of the import determinants in our AID dimer model (Fig. 4a) . However, AID FYRN is unstable and inactive. Although this would not be unexpected if a dimer was the minimal functional unit of AID 33 , we cannot rule out other structural defects impinging on the localization of AID FYRN. Solving this would require elucidation of the structure of AID by more sophisticated techniques than co-immunoprecipitation, exceeding the focus of this work. In any case, AID FYRN still supports the conformational NLS and the importance of the tertiary structure for nuclear import.
Cytoplasmic retention of AID
We show in several ways that AID is unable to diffuse into the nucleus when both active import and export are inhibited, strongly suggesting the existence of cytoplasmic retention. The C-terminal domain of AID, which we propose to be a flexible helix, seems necessary for cytoplasmic retention. This domain also bears the NES 17, 18, 24 , complicating the mapping of cytoplasmic retention determinants, which may partially overlap with it. However, comparison of the L198S and D187A D188A mutations provides good evidence that export and retention are distinct and can be separated. Structural integrity of AID may also be important, as suggested by the weaker retention of some N-terminal truncations of AID and by the apparently reduced retention of AID-FYRN, which unlike AID is not able to outcompete a heterologous NLS ( Supplementary Fig. 5 ). Coincidently, a structural determinant mediates cytoplasmic retention of APOBEC3G 49, 51 .
Regarding the identity of a putative AID cytoplasmic anchor, the observation that 3ÂFlag-AID was resistant to digitonin washing from the cytoplasm led others to propose that retention of AID is mediated by binding to tubulin 52 . We did not detect any change in AID-GFP localization after treatment with nocodazole (not shown), but other cytoskeleton molecules might be involved and further research is needed to settle this issue. Other candidates to mediate AID cytoplasmic retention may be the 14-3-3 proteins, given that AID is phosphorylated 29 . The analysis of partners in the uncharacterized AID high-molecularweight cytoplasmic complexes (K. Xue and M. Neuberger, personal communication), or comparisons between HeLa and 293T cells, which show different kinetics for AID nuclear import, may help to identify relevant cytoplasmic retention and/or nuclear import AID partners.
Functional implications
Our findings demonstrate that AID compartmentalization is not determined just by nuclear export, as the available evidences had indicated so far 18, 24 . We show that AID passive diffusion from the cytoplasm into the nucleus is hindered, and therefore AID needs to be actively imported. Both, cytoplasmic retention and nuclear import influence the biology of AID. Hindering import results in cytoplasmic retention and decreased CSR. AID variants with reduced cytoplasmic retention are no longer excluded from the nucleus in steady state, resulting in a shorter protein half-life. Thus, nuclear export seems insufficient to outweigh AID nuclear import. The observation that leptomycin B treatment of Ramos cells results in little AID nuclear translocation supports this scenario, although this should be confirmed in nontransformed B cells. The difference with AID-GFP, which accumulates in the nucleus of Ramos, could be explained by a combination of overexpression and the C-terminal tag weakening retention, just as an N-terminal tag affects import. AID is vastly confined to the cytoplasm of germinal center B cells 48, [53] [54] [55] . Only a small proportion of the B cells in rabbit appendix 48 and human tonsils 53 , and hardly any cells in unsynchronized populations overexpressing AID-GFP, seem to contain predominantly nuclear AID. In the light of our results it seems unlikely that such accumulation might be cell-cycle regulated or has much physiological significance. We would rather suggest a model in which a small proportion of nuclear AID exists at any given time, resulting from the competition between active import, nuclear export and cytoplasmic retention. This steadystate level of nuclear AID might be enough for efficient antibody gene diversification, as suggested by the CSR levels elicited by apparently exclusively cytoplasmic AID variants, such as AID V18S R19V 43 or Flag-AID. Perturbing any of the mechanisms determining AID subcellular localization will affect this equilibrium and affect the efficiency and specificity of antibody diversification.
METHODS
DNA constructs. N-terminally GFP-tagged human AID, APOBEC2 and the AID-APOBEC2 chimeras in pEGFP-C3 were a gift from S. Conticello 35 . We generated C-terminally GFP-tagged versions by PCR amplification of the open reading frames using oligonucleotides OJ60 and OJ166 for AID, OJ196 and OJ197 for APOBEC2 and OJ60-OJ166 for all AID-A2 except #5, for which OJ60-OJ197 were used (see Supplementary Methods online for all for oligonucleotide sequences). The 5¢ oligonucleotides introduced a BamHI site and a CAA triplet, a 'cold' translation initiation context to reduce expression levels, just before the ATG. The 3¢ oligonucleotides eliminated the stop codon and introduced an EcoRI site at the end of the coding regions. All fragments were cloned into BglII/EcoRI-digested pEGFP-N3. The AID protein truncations by PCR amplification using the indicated oligonucleotides (Supplementary Methods) and identically cloned into pEGFP-N3. We introduced point mutations by the Quickchange method (Stratagene) using the oligonucleotides listed in Supplementary Methods. We cloned the open reading frames of b-Lac, amplified from pUC18 using OJ213 and OJ214, and b-Gal, amplified from pIND/lacZ (Invitrogen) using OJ172 and OJ174, as EcoRI-BamHI fragments into pEGFP-N3. To construct C-terminally Flag-tagged versions of some of the proteins, EGFP was excised from pEGFP-N3 using EcoRI and NotI and replaced by a synthetic Flag/hemagglutin (HA)-tag (oligonucleotides OJ215 and OJ216). The nuclear localization signals from the SV40 large T antigen and from nucleoplasmin were constructed by annealing oligonucleotides OJ190-OJ191 and OJ192-OJ193, respectively. We used pCDNA3.1 (Invitrogen) to express untagged AID and AID mutants. Construct names throughout the manuscript indicate the actual order of the fragments in the fusion proteins.
Cell methods and microscopy. We carried out transfections as indicated in Supplementary Methods. We inhibited nuclear export by using leptomycin B (LC Labs) at 50 ng ml -1 for 4 h for 293T cells, 50 ng ml -1 for 2 h for HeLa cells and 10 ng ml -1 for 2 h for Ramos and DT40 B cells, unless otherwise indicated. We inhibited nuclear import by pretreating the cells for 1 h with freshly diluted 10 mM H 2 O 2 before any further treatment or analysis. Adherent cells were grown on coverslips, and B cell lines were allowed to attach to poly-L-Lysinecoated coverslips for 20 min at 37 1C in PBS. For immunofluorescence, the fixed cells were permeabilized in 0.25% (v/v) Triton X-100, blocked overnight and stained in PBS 5% (w/v) BSA using mouse MAb anti-Flag M2 (1:100 Sigma-Aldrich) followed by anti-mouse AlexaFluor 488 of 546 (1:1000 Invitrogen) or rat MAb anti-AID (1:100 EK2 5G9, Cell Signaling) followed by biotinylated goat anti-Rat antibodies (1:100 Abcam) detected with anti-biotin FITC (1:50 Milteny Biotec). For energy-depletion experiments, we plated transfected cells in triplicate. We subsequently incubated two of the wells in glucose-free DMEM (Wisent Inc.) supplemented with 10% (v/v) dialyzed FCS, 6 mM 2-deoxy-D-glucose (Sigma-Aldrich), to inhibit glycolysis, and 10 mM sodium azide (Bioshop), to inhibit mitochondrial respiration, for 3 h. After microscopic examination, we fixed one of the wells and incubated the remaining well for a further 3 h in complete DMEM before fixing and processing along with the untreated control. For microscopy we fixed cells in 3.7% (w/v) p-formaldehyde for 15 min, washed them three times in PBS and stained them for 15 min in PBS 0.5% (v/v) Triton-X100, 200 mg ml -1 RNase A, 10 mg ml -1 propidium iodide. They were then washed in PBS and mounted using FluorSafe (Calbiochem). Detailed confocal image acquisition and scoring is explained in Supplementary Methods. Co-immunprecipitation. 293T cells co-transfected with GFP-tagged and Flagtagged versions of the indicated proteins were homogenized in lysis buffer (20 mM Tris, pH 7.8, 137 mM NaCl, 10% (v/v) glycerol, 2mM EDTA, 1% (v/v) Triton X-100, Complete protease inhibitors (Roche)) 48 h after transfection. Lysates were incubated with 20 ml of anti-Flag M2 affinity gel (Sigma-Aldrich) for 3 h at 4 1C and eluted with 50 ml of 3Â Flag peptide (Sigma-Aldrich), following the manufacturer's protocol. Eluates were analyzed by western blot with anti-eGFP and 1:5,000 anti-Flag-HRP (Sigma-Aldrich) or 1:1000 anti-CRM1 (Santa Cruz Biotechnology). Full-length human CRM1 cloned into pCDNA3 was a gift from S. Swaminathan. GST-fusion protein pull-downs were done on cell extracts using loaded glutathione-agarose beads, as detailed in Supplementary Methods. Full-length human importin-a3 cloned in pGEX4T1 was a gift from I. Macara, and a similar construct with human importin-a5 was a gift from M. Malim. Full-length human importin-a1 was subcloned into pGEX-4T1 as an EcoRI-XhoI fragment from pJG4-5-importin-a1 45 , a gift from N. Navaratnam. Western blots were developed using SuperSignal West Pico Chemiluminiscent substrate (Thermo Scientific).
AID assays. We assayed catalytic activity of AID by a mutation assay as described 56 using the ung-deficient E. coli strain BW310 expressing AID-GFP and various mutants subcloned as NheI-NotI fragments into a modified pTrc99a. We assayed isotype class switching by retrovirally delivering AID variants into in vitro-activated B cells, obtained from Aicda À/À mice. The Institut de Recherches Cliniques de Montréal Animal Ethics Committee approved all animal handling. Purification of resting B cells from splenic lymphocytes by CD43 depletion, retroviral infection and analysis of isotype class switching to IgG1 has been described 57 . AID-GFP variants and GFP-AID were subcloned as EcoRI-NotI fragments into the pMXs retroviral vector. Untagged human AID and Flag-AID were subcloned as BamHI-NotI fragments into pMXs-ires-GFP 58 . AID stability monitoring is explained in Supplementary Methods. Structure modeling. See Supplementary Methods. Statistics. Where indicated, two experimental data sets were compared using a paired, one-tailed, Student's t-test.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
